Insulin glargine and lixisenatide and Zofran injection
Determining the interaction of Insulin glargine and lixisenatide and Zofran injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: ondansetron
Brand name: Zofran, Zofran ODT, Zuplenz
Synonyms: Zofran
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Zofran ODT
- Insulin glargine and lixisenatide-Zofran ODT Oral, Oromucosal
- Insulin glargine and lixisenatide-Zofran Oral, Oromucosal
- Insulin glargine and lixisenatide-Zohydro ER
- Insulin glargine and lixisenatide-Zohydro ER Capsules
- Insulin glargine and lixisenatide-Zoladex
- Zofran injection-Insulin glargine and lixisenatide Subcutaneous
- Zofran injection-Insulin glargine, recombinant Subcutaneous
- Zofran injection-Insulin glulisine
- Zofran injection-Insulin Glulisine (Cartridges and Pens)
- Zofran injection-Insulin Glulisine (Vials)
- Zofran injection-Insulin glulisine Subcutaneous